CYC 0.00% $1.80 cyclopharm limited

Bell Potter update snip from yesterday "Investment View: Retain...

  1. 4,689 Posts.
    lightbulb Created with Sketch. 72
    Bell Potter update snip from yesterday

    "Investment View: Retain Buy, Price Target $4.25
    We conclude that the initial roll out of Technegas in the US is proceeding and expect
    further announcements regarding subsequent contract signings in the short term. We
    have updated the earnings forecast to modestly slow the roll out of Technegas flow
    generators (FGs) as our previous forecast had underestimated the time taken to gain
    Value Analysis Committee Approvals, therefore the company is unlikely to achieve 20
    FG’s by 31 Dec 2023. The forecast now includes updated pricing assumptions and a
    series of minor adjustments. We retain our Buy rating and drop the Speculative risk
    warning. We retain our price target at $4.25."
 
watchlist Created with Sketch. Add CYC (ASX) to my watchlist
(20min delay)
Last
$1.80
Change
0.000(0.00%)
Mkt cap ! $169.5M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 500 $1.76
 

Sellers (Offers)

Price($) Vol. No.
$1.80 287 1
View Market Depth
Last trade - 16.12pm 03/05/2024 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.